Side-by-side comparison of price performance, valuation, growth, profitability, analyst targets and technical trend.
Each line starts at 100 so growth is directly comparable
| Metric | FRVO | SPHR |
|---|---|---|
| Price | $13.46 | $110.80 |
| Change today | ▼ 6.85% | ▼ 13.61% |
| Market cap | $3.97B | $3.98B |
| Return, 3 months | -43.4% | -29.2% |
| Return, year to date | – | +16.5% |
| Return, 1 year | – | +74.7% |
| P/E (TTM) | -30.1 | -57.1 |
| P/B | 1.4 | 1.8 |
| P/E percentile vs own 5y | 94th | 4th |
| Dividend yield | – | – |
| Revenue growth (YoY, latest qtr) | – | +11.0% |
| Net profit growth (YoY) | – | -125.2% |
| Gross margin | – | 51.8% |
| Operating margin | – | -19.4% |
| Net margin | – | -12.2% |
| Return on equity | – | – |
| Analyst target vs. price | +182.3% | +55.9% |
| Analyst buy share | 100% | 78% |
| RSI (14) | 36 | 22 |
| 30-day volatility | 114.9% | 56.5% |
| Max drawdown, 1 year | -68.3% | -37.2% |
| Trend read | Strong downtrend | Strong downtrend |
| Analyst consensus | Buy | Buy |
Green cells mark the best value in each row where "better" is clear-cut (lower P/E, higher margin). That is a reading of the numbers, not a recommendation. Financials are in each company's reporting currency.
